Condition
Overdose Antidote
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (2)
Early P 1 (1)
P 1 (1)
Trial Status
Completed2
Not Yet Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07072819Not ApplicableCompleted
Pilot of Training on 988 and Narcan
NCT07375498Phase 1Not Yet Recruiting
Safety and Pharmacokinetics of Rescue Liposome in Healthy Adults
NCT05367531Not ApplicableUnknownPrimary
Assessment of Injectable Medication Platforms
NCT05099614Early Phase 1CompletedPrimary
Naloxone Auto-injection in Healthy Volunteers
Showing all 4 trials